Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial
Randomized trial
Abstract
In a randomized double-blind controlled trial, add-on Viola odorata (sweet violet) improved respiratory symptoms in patients with COVID-19, supporting its traditional demulcent/expectorant use for respiratory complaints.
Referenced for these plants
How to cite
Adel Mehraban, M.S., Shirzad, M., Mohammad Taghizadeh Kashani, L., Ahmadian-Attari, M.M. and others (2022) 'Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-blind controlled trial', Journal of Ethnopharmacology, 304, pp. 116058. doi:10.1016/j.jep.2022.116058
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.